Dissociation of vasomotor and metabolic responses to levodopa has been observed in human subjects with Parkinson's disease (PD) studied with PET and in autoradiograms from 6-hydroxydopamine (6-OHDA) rat. In both species, acute levodopa administration was associated with increases in basal ganglia cerebral blood flow (CBF) with concurrent reductions in cerebral metabolic rate (CMR) for glucose in the same brain regions. In this study, we used a novel dual-tracer microPET technique to measure CBF and CMR levodopa responses in the same animal. Rats with unilateral 6-OHDA or sham lesion underwent sequential 15 O-water (H 2 15 O) and 18 F-fluorodeoxyglucose (FDG) microPET to map CBF and CMR following the injection of levodopa or saline.
Introduction
A number of early studies were conducted to examine the vasomotor effects of dopaminergic drugs in animal models and human subjects (Leenders et al., 1985; McCulloch and Edvinsson, 1980) . Studies in different species showed that the action of these agents was mediated by dopamine receptors on cerebrovascular smooth muscle cells (Edvinsson et al., 1978; Toda, 1976 ) and on neighboring astrocytes (Ruscher et al., 2012) . Dopamine binding at these sites regulates vasomotor tone in a reversible, dose-dependent manner and maintains local neurovascular coupling (Edvinsson et al., 1985; Filosa et al., 2016; Guell et al., 1982) .
The regional cerebrovascular effects of levodopa are noteworthy. This molecule crosses the blood brain barrier (BBB) through endothelial cells on brain capillaries. Studies in 6-hydroxydopamine (6-OHDA) rat models have found that chronic treatment induces changes in these blood vessels potentially altering BBB permeability and transport kinetics (Lindgren et al., 2009; Ohlin et al., 2011; Ohlin et al., 2012; Westin et al., 2006) . Of note, these microvascular changes were observed mainly in chronically levodopa-treated animals developing abnormal dyskinetic movements in response to drug. Indeed, abnormal central handling of exogenously administered levodopa is regarded as the critical upstream trigger for these movements (Cenci, 2014) .
Dissociation of neuronal and vasomotor effects has been reported as a consistent feature of acute levodopa administration in human Parkinson's disease (PD). We used dual-tracer imaging with to monitor the changes in regional cerebral blood flow (CBF) and cerebral metabolic rate for glucose (CMR) that occurred during acute levodopa administration (Hirano et al., 2008; Jourdain et al., 2015) . In these individuals, intravenous levodopa infusion lowered local CMR in 
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